Material Safety Data Sheet PERMANONE 31-66 SECTION 1. CHEMICAL PRODUCT AND COMPANY INFORMATION Product Name Chemical Name Synonym MSDS Number Chemical Family Chemical Formulation EPA Registration No. Canadian Registrat. No.
Aventis95 Chestnut Ridge RoadMontvale, NJ 07645USA
! For Product Use Information: (800)331-2867 Monday through Friday 8:00AM-4:30PM For Medical Emergency contact DART: (800) 334-7577 24 Hours/Day For Transportation Emergency CHEMTREC: (800) 424-9300 24 Hours/Day
SECTION 2. COMPOSITION/INFORMATION ON INGREDIENTS Component Name Concentration % by Weight SECTION 3. HAZARDS IDENTIFICATION NOTE: Please refer to Section 11 for detailed toxicological information.Emergency Overview
Health: Harmful if swallowed, absorbed through skin or inhaled. Prolonged orfrequently repeated skin contact may cause allergic reactions in someindividuals. Avoid contact with skin, eyes or clothing. Avoid breathing vapors. Wash thoroughly with soap and water after handling.
Environmental: This product is extremely toxic to fish and aquatic invertebratesand highly toxic to bees. Physical State Appearance Routes of Exposure
Ingestion, inhalation, and skin contact. Immediate Effects Material Safety Data Sheet PERMANONE 31-66
Harmful if absorbed. Prolonged or frequently repeated skin contact may causeallergic reactions in some individuals. Slightly irritating. Ingestion Inhalation Chronic or Delayed
See Section 11 for carcinogenic/oncogenic information on piperonyl butoxide
Long-Term Medical Conditions Aggravated by Exposure SECTION 4. FIRST AID MEASURES
Flush eyes with plenty of water. Get medical attention if irritation persists.
Wash with plenty of soap and water and get medical attention. Ingestion
Call a physician or Poison Control Center. Drink one or two glasses of water andinduce vomiting by touching back of throat with finger. Do not induce vomiting orgive anything by mouth to an unconscious person. Inhalation
Remove victim to fresh air. If not breathing, give artificial respiration. Get medicalattention. Note to Physician
This product contains a pyrethroid. If a small amount is ingested (or if treatmentis delayed) oral administration of large amounts of activated charcoal and acathartic is probably sufficient therapy.
Do not administer milk, cream or other substances containing vegetable oranimal fats, which enhance the absorption of lipophilic substances. SECTION 5. FIRE FIGHTING MEASURES Flash Point Suitable Extinguishing
Carbon dioxide, dry chemical, foam or water. Fire Fighting
As in any fire, wear self-contained breathing apparatus pressure-demand,
Instructions
MSHA/NIOSH approved (or equivalent) and full protective gear. SECTION 6. ACCIDENTAL RELEASE MEASURES General and Disposal
Soak up with an absorbent material such as sand, sawdust, earth, fuller's earth,etc. SECTION 7. HANDLING AND STORAGE Handling Procedures
Avoid contact with skin, eyes or clothing. Avoid breathing vapors. Material Safety Data Sheet PERMANONE 31-66 Storing Procedures
Do not store at temperatures below 40°F (4.5°C). If this material has beenexposed to temperatures below 40°F (4.5°C) there may be precipitation. Checkfor crystalization. If evident, warm to 80°F (26.5°C) and thoroughly mix beforeusing. DO NOT USE OPEN FLAME. Work/Hygienic
Wash thoroughly with soap and water after handling. Procedures
Remove contaminated clothing and wash before reuse. SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION Eye/Face Protection Body Protection Exposure Limits SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES Appearance Physical State Specific Gravity Solubility (in water) SECTION 10. STABILITY AND REACTIVITY Chemical Stability Incompatibility Hazardous Polymerization (Conditions to avoid) SECTION 11. TOXICOLOGICAL INFORMATION Acute Oral Toxicity Acute Dermal Toxicity Acute Inhalation Toxicity
rat 17.56 mg/l for DOT purposes (1.0 hr)
Material Safety Data Sheet PERMANONE 31-66 Skin Irritation Eye Irritation
rabbit Tox Category III Mildly irritating
Sensitization
The above acute toxicity data from Permanone 31% Butacide 66% Manufacturing Concentrate; EPA Reg. No. 432-1150, which contains 31% permethrin and 66% piperonyl butoxide. Chronic Toxicity
A statistically significant increase in the incidence of lung and liver tumors wasobserved in female mice receiving diets containing 375 and 750 mg/kg/day ofpermethrin technical over 85 weeks.
A statistically significant increase in the number of benign liver tumors appearedin mice fed piperonyl butoxide technical at doses which far exceed anyanticipated daily human intake. Independent and industry toxicological expertswho have reviewed the data agree that the findings of the study do not indicate ahealth risk to human beings. Assessment Carcinogenicity Material Safety Data Sheet PERMANONE 31-66 SECTION 12. ECOLOGICAL INFORMATION Environmental
This product is extremely toxic to fish and aquatic organisms. For terrestrial
Precautions
uses, do not apply directly to water, or to areas where surface water is present,or to intertidal areas below mean high water mark. Do not apply when weatherconditions favor drift from areas treated. Drift or runoff from treated areas may behazardous to aquatic organisms in neighboring areas. Do not contaminate waterby cleaning of equipment or disposal of equipment wash waters. Do not applywhen wind speeds exceed 10 mph.
This product is highly toxic to bees exposed to direct treatment or residuesremaining on the treated areas. Do not apply this product or allow drift whenbees are actively visiting the treatment area. Applications should be timed toprovide maximum possible interval between treatment and the next period of beeactivity. SECTION 13. DISPOSAL CONSIDERATIONS General Disposal
Pesticide Disposal: Wastes resulting from use of this product may be disposed of
Guidance
on site or at an approved waste disposal facility. Container Disposal
Triple rinse (or equivalent). Then offer for recycling or reconditioning, or punctureand dispose of in a sanitary landfill, or by other procedures approved by stateand local authorities. SECTION 14. TRANSPORT INFORMATION SECTION 15. REGULATORY INFORMATION US Federal EPA Registration No. TSCA list TSCA 12b export notification SARA Title III - section 302 - notification and information SARA Title III - section 313 - toxic chemical release reporting US States Regulatory CA Prop65 This product contains a chemical known to the state of California to cause cancer.
This product contains a chemical known to the state of California to cause birth defects or otherreproductive harm. US State right-to-know ingredients Material Safety Data Sheet PERMANONE 31-66 Canadian Regulations Canadian Registrat. No. Canadian Domestic Substance List Environmental Clean Water Section 307 Priority Pollutants Safe Drinking Water Act Maximum Contaminant Levels International Regulations EU Classification European Inventory of Existing Commercial Substances (EINECS) SECTION 16. OTHER INFORMATION
REVISED SECTIONS: MSDS REVISION INDICATOR: New Format
PREPARED BY: Regulatory Department PHONE: 800-438-5837 SUPERCEDES MSDS DATED: 05/19/2000
Print Date: 09/25/2001Supersedes MSDS, which is older than: 09/25/2001
This information is provided in good faith but without express or implied warranty. Buyer assumes allresponsibility for safety and use not in accordance with label instructions. The product names are registeredtrademarks of Aventis.
Attachment 11A Page 1 of 2 RIVERSIDE COUNTY DEPARTMENT OF MENTAL HEALTH ADULT MEDICAL HISTORY SUMMARY Part I – TO BE COMPLETED BY PATIENT OR PATIENT INFORMANT (Please Print) Patient’s Name: _________________ (First) (Middle) (Last) (Maiden) Informant Patient/Relationship: _________________ Current Physician: _________________ (Addr
T A B L E T S / C H E W A B L E T A B L E T S / O R A L G R A N U L E S Composition Each tablet/sachet contains: Active Ingredient Tablets: Each 10 mg Tablet contains 10.4 mg montelukast sodium, equivalent to 10mg free acid. Chewable Tablets: Each 5 mg chewable tablet contains 5.2 mg montelukast sodium, equivalent to 5 mg free acid. Each 4 mg chewable tablet contains 4.2 mg monteluka
Material Safety Data Sheet